Literature DB >> 18204840

Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals.

Tomohiro Nabekura1, Takeshi Yamaki, Kazuyuki Ueno, Shuji Kitagawa.   

Abstract

PURPOSE: For the development of a safe and effective dual inhibitor of anticancer drug efflux transporters P-glycoprotein and multidrug resistance protein 1 (MRP1) to conquer multidrug resistance, we investigated the effects of dietary phytochemicals on the functions of P-glycoprotein and MRP1.
METHODS: The effects of dietary phytochemicals on the functions of P-glycoprotein and MRP1 were investigated using P-glycoprotein-overexpressing human carcinoma KB-C2 cells and human MRP1 gene-transfected KB/MRP cells. The effects of natural compounds found in dietary supplements, herbs, and foods such as sesame, ginkgo, soybean, and licorice were evaluated.
RESULTS: The accumulation of daunorubicin, a fluorescent substrate of P-glycoprotein, increased in the presence of sesamin, ginkgolic acid, matairesinol, glycyrrhetinic acid, glabridin, and phyllodulcin in KB-C2 cells. Glycyrrhetinic acid and matairesinol also increased the accumulation of calcein, a fluorescent substrate of MRP1, in KB/MRP cells. KB-C2 and KB/MRP cells were sensitized to anticancer drugs by glycyrrhetinic acid, showing that glycyrrhetinic acid reverses multidrug resistance. The verapamil-stimulated P-glycoprotein ATPase activity was inhibited by glycyrrhetinic acid. Glycyrrhetinic acid stimulated the ATPase activity of MRP1.
CONCLUSION: These results suggest that dietary phytochemicals, such as glycyrrhetinic acid found in licorice, have dual inhibitory effects on P-glycoprotein and MRP1 and might become useful to enhance the efficacy of cancer chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18204840     DOI: 10.1007/s00280-007-0676-4

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  27 in total

Review 1.  Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood-Cerebrospinal Fluid Barrier and Blood-Brain Barrier.

Authors:  Lilian W Kibathi; SoHyun Bae; Scott R Penzak; Parag Kumar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

2.  A novel pharmacotherapy approach using P-glycoprotein (PGP/ABCB1) efflux inhibitor combined with ivermectin to reduce alcohol drinking and preference in mice.

Authors:  Joshua Silva; Sheraz Khoja; Liana Asatryan; Eunjoo Pacifici; Daryl L Davies
Journal:  Alcohol       Date:  2020-04-08       Impact factor: 2.405

3.  Phytochemical Inhibition of Multidrug Resistance Protein-1 as a Therapeutic Strategy for Hemangioendothelioma.

Authors:  Ayan Biswas; Emma C Clark; Chandan K Sen; Gayle M Gordillo
Journal:  Antioxid Redox Signal       Date:  2016-11-09       Impact factor: 8.401

Review 4.  Phytochemistry and biological properties of glabridin.

Authors:  Charlotte Simmler; Guido F Pauli; Shao-Nong Chen
Journal:  Fitoterapia       Date:  2013-07-10       Impact factor: 2.882

Review 5.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

Review 6.  Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents.

Authors:  Reen-Yen Kuo; Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2009-08-13       Impact factor: 13.423

7.  Lack of effect of continuous glycyrrhizin administration on the pharmacokinetics of the P-glycoprotein substrate talinolol in healthy volunteers.

Authors:  Miao Yan; Ping-Fei Fang; Huan-De Li; Ping Xu; Yi-Ping Liu; Feng Wang; Hua-Lin Cai; Qin-You Tan
Journal:  Eur J Clin Pharmacol       Date:  2012-09-15       Impact factor: 2.953

Review 8.  Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer's disease management.

Authors:  Sumit Jain; Vijay Rathod; Rameshwar Prajapati; Prajwal P Nandekar; Abhay T Sangamwar
Journal:  Mol Divers       Date:  2014-09-12       Impact factor: 2.943

Review 9.  Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.

Authors:  Chung-Pu Wu; Shinobu Ohnuma; Suresh V Ambudkar
Journal:  Curr Pharm Biotechnol       Date:  2011-04       Impact factor: 2.837

Review 10.  Transport processes of radiopharmaceuticals and -modulators.

Authors:  Thomas Efferth; Peter Langguth
Journal:  Radiat Oncol       Date:  2011-06-06       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.